CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-External]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]

CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-NC]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]

CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-UCSD]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]

CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-UCSF]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]

CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-UFL]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]

CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-NYC]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]

CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-Boston, MA]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]

CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-Miami, FL]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]

CR-04.09.26-BCFS001883-GentiBio-Neff-327 [Landing Page-Duarte, CA]

Apply Now Type 1 DiabetesResearch Study The POLARIS Study is evaluating a one-time, investigational cell therapy for adults recently diagnosed with type 1 diabetes. This therapy, made from a participant’s own blood cells, is designed to help restore immune balance and slow disease progression. Unlike current treatments, it aims to address the underlying cause of […]